These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 17596711)
1. Increased Abeta production leads to intracellular accumulation of Abeta in flotillin-1-positive endosomes. Rajendran L; Knobloch M; Geiger KD; Dienel S; Nitsch R; Simons K; Konietzko U Neurodegener Dis; 2007; 4(2-3):164-70. PubMed ID: 17596711 [TBL] [Abstract][Full Text] [Related]
2. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice. van Groen T; Kiliaan AJ; Kadish I Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076 [TBL] [Abstract][Full Text] [Related]
3. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment. Leon WC; Canneva F; Partridge V; Allard S; Ferretti MT; DeWilde A; Vercauteren F; Atifeh R; Ducatenzeiler A; Klein W; Szyf M; Alhonen L; Cuello AC J Alzheimers Dis; 2010; 20(1):113-26. PubMed ID: 20164597 [TBL] [Abstract][Full Text] [Related]
4. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau. Shin RW; Ogino K; Shimabuku A; Taki T; Nakashima H; Ishihara T; Kitamoto T Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643 [TBL] [Abstract][Full Text] [Related]
5. RAGE does not affect amyloid pathology in transgenic ArcAbeta mice. Vodopivec I; Galichet A; Knobloch M; Bierhaus A; Heizmann CW; Nitsch RM Neurodegener Dis; 2009; 6(5-6):270-80. PubMed ID: 20145420 [TBL] [Abstract][Full Text] [Related]
6. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain. Güntert A; Döbeli H; Bohrmann B Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022 [TBL] [Abstract][Full Text] [Related]
7. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease. Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372 [TBL] [Abstract][Full Text] [Related]
8. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease. Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725 [TBL] [Abstract][Full Text] [Related]
9. A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition. Flood DG; Lin YG; Lang DM; Trusko SP; Hirsch JD; Savage MJ; Scott RW; Howland DS Neurobiol Aging; 2009 Jul; 30(7):1078-90. PubMed ID: 18053619 [TBL] [Abstract][Full Text] [Related]
10. Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes. Howlett DR; Richardson JC; Austin A; Parsons AA; Bate ST; Davies DC; Gonzalez MI Brain Res; 2004 Aug; 1017(1-2):130-6. PubMed ID: 15261108 [TBL] [Abstract][Full Text] [Related]
11. Peripheral and central biodistribution of (111)In-labeled anti-beta-amyloid autoantibodies in a transgenic mouse model of Alzheimer's disease. Bacher M; Depboylu C; Du Y; Noelker C; Oertel WH; Behr T; Henriksen G; Behe M; Dodel R Neurosci Lett; 2009 Jan; 449(3):240-5. PubMed ID: 18786612 [TBL] [Abstract][Full Text] [Related]
12. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease. Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506 [TBL] [Abstract][Full Text] [Related]
13. mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease. Lafay-Chebassier C; Paccalin M; Page G; Barc-Pain S; Perault-Pochat MC; Gil R; Pradier L; Hugon J J Neurochem; 2005 Jul; 94(1):215-25. PubMed ID: 15953364 [TBL] [Abstract][Full Text] [Related]
14. LRP in amyloid-beta production and metabolism. Bu G; Cam J; Zerbinatti C Ann N Y Acad Sci; 2006 Nov; 1086():35-53. PubMed ID: 17185504 [TBL] [Abstract][Full Text] [Related]
15. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease. Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635 [TBL] [Abstract][Full Text] [Related]
16. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease. Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161 [TBL] [Abstract][Full Text] [Related]
17. Intracellular amyloid-beta in Alzheimer's disease. LaFerla FM; Green KN; Oddo S Nat Rev Neurosci; 2007 Jul; 8(7):499-509. PubMed ID: 17551515 [TBL] [Abstract][Full Text] [Related]
18. Hypoxia increases Abeta generation by altering beta- and gamma-cleavage of APP. Li L; Zhang X; Yang D; Luo G; Chen S; Le W Neurobiol Aging; 2009 Jul; 30(7):1091-8. PubMed ID: 18063223 [TBL] [Abstract][Full Text] [Related]
19. PDAPP; YFP double transgenic mice: a tool to study amyloid-beta associated changes in axonal, dendritic, and synaptic structures. Brendza RP; O'Brien C; Simmons K; McKeel DW; Bales KR; Paul SM; Olney JW; Sanes JR; Holtzman DM J Comp Neurol; 2003 Feb; 456(4):375-83. PubMed ID: 12532409 [TBL] [Abstract][Full Text] [Related]
20. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Simard AR; Soulet D; Gowing G; Julien JP; Rivest S Neuron; 2006 Feb; 49(4):489-502. PubMed ID: 16476660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]